Home/Filings/4/0001209191-23-017553
4//SEC Filing

Loewen Andrea 4

Accession 0001209191-23-017553

CIK 0001358762other

Filed

Mar 8, 7:00 PM ET

Accepted

Mar 9, 4:47 PM ET

Size

11.3 KB

Accession

0001209191-23-017553

Insider Transaction Report

Form 4
Period: 2023-03-07
Loewen Andrea
SVP, Global Regulatory Affairs
Transactions
  • Exercise/Conversion

    Class A common stock

    2023-03-07$27.32/sh+15,000$409,80057,793 total
  • Sale

    Class A common stock

    2023-03-07$84.44/sh1,200$101,32838,757 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2023-03-0715,00035,000 total
    Exercise: $27.32Exp: 2032-01-03Class A common stock (15,000 underlying)
  • Sale

    Class A common stock

    2023-03-07$83.36/sh17,836$1,486,80939,957 total
Footnotes (3)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $83.00 to $83.90. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $84.00 to $84.80. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  • [F3]The options began vesting in sixteen equal installments beginning on April 3, 2022. On February 28, 2023, based on the satisfaction of certain performance criteria, the options scheduled to vest on April 3, 2025, July 3, 2025, October 3, 2025, and January 3, 2026 vested immediately. The remainder of the vesting schedule will continue as originally stated, subject to continued service through each vesting date.

Issuer

REATA PHARMACEUTICALS INC

CIK 0001358762

Entity typeother

Related Parties

1
  • filerCIK 0001591100

Filing Metadata

Form type
4
Filed
Mar 8, 7:00 PM ET
Accepted
Mar 9, 4:47 PM ET
Size
11.3 KB